Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
9 Leser
Artikel bewerten:
(0)

Inverness Medical Innovations to Present at SG Cowen & Co.'s 26th Annual Health Care Conference


WALTHAM, Mass., Feb. 28 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. , a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend SG Cowen & Co.'s upcoming 26th Annual Health Care Conference scheduled for March 6th through 9th, 2006 at The Boston Marriott Copley Place in Boston, Massachusetts. Ron Zwanziger, Chief Executive Officer, and Chris Lindop, Chief Financial Officer, will attend. Their presentation is scheduled for Monday, March 6, 2006 at 4:50 p.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invernessmedical.com/investorrelations.cfm and through SG Cowen's website at http://www.cowen.com/. A webcast replay will be available via the links above until June 6th, 2006.

During their presentation, Mr. Zwanziger or Mr. Lindop may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

An updated investor presentation to be distributed at the conference will be made available to the public in advance of the webcast on the company's website via the link provided above.

Inverness Medical Innovations is a leading global developer of advanced diagnostic devices and is presently exploring new opportunities for its proprietary electrochemical and other technologies in a variety of professional diagnostic and consumer-oriented applications including immuno-diagnostics with a focus on women's health, cardiology and infectious disease. The company's new product development efforts, as well as its position as a leading supplier of consumer pregnancy and fertility/ovulation tests and rapid point-of-care diagnostics, are supported by the strength of its intellectual property portfolio. The company is headquartered in Waltham, Massachusetts.

First Call Analyst:
FCMN Contact:
Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2006 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.